Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Business Segments — Other segment expenses

Similar metrics at other companies

Gulfport Energy logo
GPORReportable Segments — Other segment expenses
$2.3M+2,833%
California Resources logo
CRCTotal Reportable Segments — Other segment expenses
$60M-1.6%
BellRing Brands logo
BRBRReportable Segment — Other segment expenses
$55.2M-12.2%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other segment expenses
$5000.0%
BJ's Wholesale Club Holdings, Inc. logo
BJReportable Segment — Other segment expenses
$1.18B+34.8%
i3 Verticals, Inc. logo
IIIVReportable Segment — Other segment expenses
$14.4M+6.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Elsunersen8,1411,31711,3382,078
Other early stage assets5,4711,4178,7132,522
Personnel-related expenses18,94311,91336,67324,943
Stock-based compensation expense11,3097,77028,42116,556
Depreciation expense33467293
Other segment expenses(a)12,8516,75324,94015,129
Other income, net13,1844,94026,48310,372
Consolidated net loss$(83,720)$(71,127)$(176,281)$(140,423)

Item 1. Financial Statements (Unaudited)

FAQ

What is Praxis Precision Medicines, Inc.'s business segments — other segment expenses?
Praxis Precision Medicines, Inc. (PRAX) reported business segments — other segment expenses of $12.85M in Q2 2026.
How has Praxis Precision Medicines, Inc.'s business segments — other segment expenses changed year-over-year?
Praxis Precision Medicines, Inc.'s business segments — other segment expenses increased by 90.3% year-over-year, from $6.75M to $12.85M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s business segments — other segment expenses?
Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s business segments — other segment expenses has grown at a 24.3% compound annual growth rate (CAGR), from $18.99M to $29.33M.
What does business segments — other segment expenses mean?
This metric captures miscellaneous operational costs within the business segment that are not classified as personnel, stock-based compensation, or depreciation. It typically includes facility overhead, third-party research services, and general administrative costs. It provides visibility into the 'burn rate' of the segment's day-to-day activities.

Ask your AI about Praxis Precision Medicines, Inc.'s business segments — other segment expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude